Patients need to self-inject twice daily, which may prove inconvenient and hinder consistent use
But the others are more interesting
Retatrutide cannot currently be legally prescribed or sold as a finished drug product for individual use
It was discovered that weight loss was also associated with these drugs, and through developing more GLP-1 medications in the last several years, their popularity has grown
What the research shows Hair shedding on GLP1 medications is primarily a condition called telogen effluvium, a temporary increase in hair loss triggered by physical stress on the body
However, worth noting, Retatrutide remains a research compound only , it isnt approved for any therapeutic use, and all comparisons refer strictly to pre-clinical research findings